TGen sequencing test enables precise identification of drug-resistant TB

(The Translational Genomics Research Institute) Two studies led by the Translational Genomics Research Institute (TGen) and the University of California San Francisco (UCSF) document how a new advanced genetic sequencing approach can help thwart the growing worldwide threat posed by drug-resistant mutations of tuberculosis (TB). The threat of TB is increasing in some places as mutant versions of the disease become more and more resistant to current drug treatments.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news